Nordic Nanovector ASA: Results for the Third Quarter 2020
The Pharma Data
NOVEMBER 18, 2020
. Approval of amendments to PARADIGME protocol is proceeding as planned and completed in the best-recruiting countries Designed to enlarge the eligible patient population and increase the rate of enrolment into the trial. 59 patients enrolled as of 18 November 2020. Financial Highlights.
40 
Let's personalize your content